Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent.

Newberg AB, Ray R, Scheuermann J, Wintering N, Saffer J, Schmitz A, Freifelder R, Karp J, Lerman C, Divgi C.

Nucl Med Commun. 2009 Apr;30(4):314-8. doi: 10.1097/MNM.0b013e328329a0ec.

PMID:
19242386
2.

Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes.

Mozley PD, Stubbs JB, Dresel SH, Barraclough ED, Smith T, Patel M, Finkelman C, Sparks RB, Thakur ML, Mathur A, Alavi A.

J Nucl Med. 1999 Apr;40(4):625-30.

3.

Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.

Newberg AB, Plössl K, Mozley PD, Stubbs JB, Wintering N, Udeshi M, Alavi A, Kauppinen T, Kung HF.

J Nucl Med. 2004 May;45(5):834-41.

4.

Radiation dose estimates in humans for (11)C-acetate whole-body PET.

Seltzer MA, Jahan SA, Sparks R, Stout DB, Satyamurthy N, Dahlbom M, Phelps ME, Barrio JR.

J Nucl Med. 2004 Jul;45(7):1233-6.

5.

Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.

O'Keefe GJ, Saunder TH, Ng S, Ackerman U, Tochon-Danguy HJ, Chan JG, Gong S, Dyrks T, Lindemann S, Holl G, Dinkelborg L, Villemagne V, Rowe CC.

J Nucl Med. 2009 Feb;50(2):309-15. doi: 10.2967/jnumed.108.055756.

6.

Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.

Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Någren KA, Rinne JO.

J Nucl Med. 2007 Jan;48(1):128-33.

7.

Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease.

Newberg AB, Wintering NA, Plössl K, Hochold J, Stabin MG, Watson M, Skovronsky D, Clark CM, Kung MP, Kung HF.

J Nucl Med. 2006 May;47(5):748-54.

8.

Comparison of [11C]diprenorphine and [11C]carfentanil in vivo binding to opiate receptors in man using a dual detector system.

Villemagne VL, Frost JJ, Dannals RF, Lever JR, Tanada S, Natarajan TK, Wilson AA, Ravert HT, Wagner HN Jr.

Eur J Pharmacol. 1994 May 12;257(1-2):195-7.

PMID:
7915990
9.

Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.

Mozley PD, Stubbs JB, Plössl K, Dresel SH, Barraclough ED, Alavi A, Araujo LI, Kung HF.

J Nucl Med. 1998 Dec;39(12):2069-76.

10.

Estimation of internal absorbed dose of L-[methyl-11C]methionine using whole-body positron emission tomography.

Deloar HM, Fujiwara T, Nakamura T, Itoh M, Imai D, Miyake M, Watanuki S.

Eur J Nucl Med. 1998 Jun;25(6):629-33.

PMID:
9618578
11.

Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers.

Bottlaender M, Valette H, Roumenov D, Dollé F, Coulon C, Ottaviani M, Hinnen F, Ricard M.

J Nucl Med. 2003 Apr;44(4):596-601.

12.

Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects.

Hirvonen J, Aalto S, Hagelberg N, Maksimow A, Ingman K, Oikonen V, Virkkala J, Någren K, Scheinin H.

Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):275-86. doi: 10.1007/s00259-008-0935-6.

PMID:
18779961
13.

Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers.

Ribeiro MJ, Ricard M, Lièvre MA, Bourgeois S, Emond P, Gervais P, Dollé F, Syrota A.

Nucl Med Biol. 2007 May;34(4):465-70.

PMID:
17499737
14.

Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET.

Slifstein M, Hwang DR, Martinez D, Ekelund J, Huang Y, Hackett E, Abi-Dargham A, Laruelle M.

J Nucl Med. 2006 Feb;47(2):313-9.

15.

1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.

Virta JR, Tolvanen T, Någren K, Brück A, Roivainen A, Rinne JO.

J Nucl Med. 2008 Mar;49(3):347-53. doi: 10.2967/jnumed.107.047233.

16.

Radiosynthesis of an opiate receptor binding radiotracer: [11C]carfentanil.

Dannals RF, Ravert HT, Frost JJ, Wilson AA, Burns HD, Wagner HN Jr.

Int J Appl Radiat Isot. 1985 Apr;36(4):303-6.

PMID:
2991142
17.

Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.

Beauregard JM, Croteau E, Ahmed N, van Lier JE, Bénard F.

J Nucl Med. 2009 Jan;50(1):100-7. doi: 10.2967/jnumed.108.057000.

18.

Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET.

Herzog H, Elmenhorst D, Winz O, Bauer A.

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1499-506. doi: 10.1007/s00259-008-0753-x.

PMID:
18373090
19.

Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase.

Boileau I, Bloomfield PM, Rusjan P, Mizrahi R, Mufti A, Vitcu I, Kish SJ, Houle S, Wilson AA, Tong J.

J Nucl Med. 2014 Dec;55(12):1993-7. doi: 10.2967/jnumed.114.146464.

20.

Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.

Obrzut SL, Koren AO, Mandelkern MA, Brody AL, Hoh CK, London ED.

Nucl Med Biol. 2005 Nov;32(8):869-74.

Supplemental Content

Support Center